A Spanish-language translation for the U.S. of the type 2 diabetes stigma assessment scale (DSAS-2 Spa-US).
psychometrics
social stigma
survey
translation
type 2 diabetes
Journal
Frontiers in clinical diabetes and healthcare
ISSN: 2673-6616
Titre abrégé: Front Clin Diabetes Healthc
Pays: Switzerland
ID NLM: 9918266295306676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
09
2022
accepted:
05
12
2022
medline:
31
3
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
epublish
Résumé
Diabetes stigma is recognized to negatively impact health-related outcomes for people living with type 2 diabetes (T2D), but there is a dearth of evidence among U.S. Latino adults with T2D. Our aim was to develop a Spanish-language translation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2) and examine its psychometric properties among U.S. Latino adults with T2D. The translation was developed through a multi-step process, including a focus group with community health workers (n=5) and cognitive debriefing interviews with Latino adults with T2D (n=8). It was field-tested in an online survey of U.S. Latino adults with T2D, recruited Among 817 U.S. Latino adults with T2D who participated in the online survey, 517 completed the Spanish-language DSAS-2 (DSAS Spa-US) and were eligible for the study (mean age 54 ± 10 years, and 72% female). Exploratory factor analysis supported a single-factor solution (eigenvalue=8.20), accounting for 82% of shared variance among the 19 items, all loading ≥ 0.5. Internal consistency reliability was high (α=0.93). As expected, strong, positive correlations were observed between diabetes stigma and general chronic illness stigma (r The DSAS-2 Spa-US is a version of the DSAS-2, translated into Spanish, that has good psychometric properties for assessing diabetes stigma in U.S. Latino adults with T2D.
Sections du résumé
Background
UNASSIGNED
Diabetes stigma is recognized to negatively impact health-related outcomes for people living with type 2 diabetes (T2D), but there is a dearth of evidence among U.S. Latino adults with T2D. Our aim was to develop a Spanish-language translation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2) and examine its psychometric properties among U.S. Latino adults with T2D.
Methods
UNASSIGNED
The translation was developed through a multi-step process, including a focus group with community health workers (n=5) and cognitive debriefing interviews with Latino adults with T2D (n=8). It was field-tested in an online survey of U.S. Latino adults with T2D, recruited
Results
UNASSIGNED
Among 817 U.S. Latino adults with T2D who participated in the online survey, 517 completed the Spanish-language DSAS-2 (DSAS Spa-US) and were eligible for the study (mean age 54 ± 10 years, and 72% female). Exploratory factor analysis supported a single-factor solution (eigenvalue=8.20), accounting for 82% of shared variance among the 19 items, all loading ≥ 0.5. Internal consistency reliability was high (α=0.93). As expected, strong, positive correlations were observed between diabetes stigma and general chronic illness stigma (r
Conclusion
UNASSIGNED
The DSAS-2 Spa-US is a version of the DSAS-2, translated into Spanish, that has good psychometric properties for assessing diabetes stigma in U.S. Latino adults with T2D.
Identifiants
pubmed: 36992721
doi: 10.3389/fcdhc.2022.1057559
pmc: PMC10012130
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1057559Informations de copyright
Copyright © 2022 Joiner, Adams, Bayrakdar and Speight.
Déclaration de conflit d'intérêts
JS is the Director of the Australian Centre for Behavioural Research in Diabetes, which owns the copyright of the DSAS-2, including all translations. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diabet Med. 2018 May;35(5):658-662
pubmed: 29417612
Res Aging. 2004;26(6):655-672
pubmed: 18504506
Am J Public Health. 2013 May;103(5):813-21
pubmed: 23488505
BMJ Open. 2016 Mar 02;6(3):e009723
pubmed: 26936903
Diabet Med. 2020 Mar;37(3):493-503
pubmed: 31984543
Diabet Med. 2021 Jan;38(1):e14387
pubmed: 32799378
Patient. 2013;6(1):1-10
pubmed: 23322536
Biomedica. 2022 May 01;42(Sp. 1):41-54
pubmed: 35866729
Psychol Health Med. 2006 Aug;11(3):277-87
pubmed: 17130065
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Clin Diabetes. 2017 Jan;35(1):27-34
pubmed: 28144043
Annu Rev Public Health. 2006;27:1-28
pubmed: 16533107
BMJ Open. 2013 Nov 18;3(11):e003384
pubmed: 24247325
J Immigr Minor Health. 2020 Apr;22(2):345-352
pubmed: 30963348
Span J Psychol. 2016 Oct 14;19:E66
pubmed: 27737723
Cultur Divers Ethnic Minor Psychol. 2014 Jul;20(3):463-468
pubmed: 25045957
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Diabetes Care. 2016 Dec;39(12):2141-2148
pubmed: 27515964
J Gen Intern Med. 2006 Jun;21(6):547-52
pubmed: 16808734
Int J Behav Med. 2013 Sep;20(3):450-60
pubmed: 22639392
Diabetes Care. 2005 Mar;28(3):626-31
pubmed: 15735199
Clin Diabetes. 2020 Oct;38(4):371-381
pubmed: 33132507
J Clin Endocrinol Metab. 2012 Sep;97(9):E1579-639
pubmed: 22730516
Diabetes Res Clin Pract. 2020 Oct;168:108387
pubmed: 32858100
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852